Bjørn Risberg

6.2k total citations
131 papers, 4.6k citations indexed

About

Bjørn Risberg is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bjørn Risberg has authored 131 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 32 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Bjørn Risberg's work include Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cancer Genomics and Diagnostics (14 papers). Bjørn Risberg is often cited by papers focused on Ovarian cancer diagnosis and treatment (24 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Cancer Genomics and Diagnostics (14 papers). Bjørn Risberg collaborates with scholars based in Norway, Sweden and Switzerland. Bjørn Risberg's co-authors include Ben Davidson, Aasmund Berner, Claes G. Tropé, Gunnar B. Kristensen, Reuven Reich, Jahn M. Nesland, Hiep Phuc Dong, Magne Bryne, Ernst Simonsen and Claes G. Tropé and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Bjørn Risberg

129 papers receiving 4.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bjørn Risberg 1.8k 1.4k 877 788 761 131 4.6k
Makoto Saegusa 1.8k 1.0× 1.3k 1.0× 680 0.8× 430 0.5× 565 0.7× 163 3.8k
K. Czerwenka 1.5k 0.8× 1.3k 0.9× 646 0.7× 781 1.0× 557 0.7× 179 4.6k
Reinhard Horvat 1.8k 1.0× 1.4k 1.0× 1.0k 1.2× 450 0.6× 474 0.6× 106 4.2k
Claes G. Tropé 1.4k 0.8× 1.2k 0.9× 787 0.9× 1.2k 1.5× 531 0.7× 149 3.8k
Stefania Bellone 1.8k 1.0× 2.4k 1.7× 761 0.9× 922 1.2× 571 0.8× 155 5.4k
Paulette Mhawech‐Fauceglia 1.9k 1.1× 2.0k 1.5× 689 0.8× 651 0.8× 676 0.9× 126 5.0k
Kenjiro Sawada 2.7k 1.5× 1.3k 1.0× 1.5k 1.7× 789 1.0× 409 0.5× 137 5.0k
Jakob Dupont 2.5k 1.4× 1.7k 1.2× 505 0.6× 935 1.2× 582 0.8× 111 5.1k
Elisabeth Müller‐Holzner 2.1k 1.2× 1.5k 1.1× 962 1.1× 506 0.6× 308 0.4× 99 4.3k
Karin Milde‐Langosch 3.2k 1.9× 1.9k 1.4× 1.8k 2.0× 429 0.5× 551 0.7× 130 5.6k

Countries citing papers authored by Bjørn Risberg

Since Specialization
Citations

This map shows the geographic impact of Bjørn Risberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørn Risberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørn Risberg more than expected).

Fields of papers citing papers by Bjørn Risberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørn Risberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørn Risberg. The network helps show where Bjørn Risberg may publish in the future.

Co-authorship network of co-authors of Bjørn Risberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørn Risberg. A scholar is included among the top collaborators of Bjørn Risberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørn Risberg. Bjørn Risberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russnes, Hege G., Xing Zhao, Bjørn Risberg, et al.. (2014). Nuclear CSPP1 expression defined subtypes of basal-like breast cancer. British Journal of Cancer. 111(2). 326–338. 9 indexed citations
2.
Kaarbø, Mari, Margrethe Larsdatter Storm, Su Qu, et al.. (2013). TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer. PLoS ONE. 8(7). e69398–e69398. 24 indexed citations
3.
Kildal, Wanja, Francesca Micci, Bjørn Risberg, et al.. (2011). Genomic imbalances in endometrial adenocarcinomas — Comparison of DNA ploidy, karyotyping and comparative genomic hybridization. Molecular Oncology. 6(1). 98–107. 3 indexed citations
4.
Wang, Ling, Yang Jin, Yke Jildouw Arnoldussen, et al.. (2010). STAMP1 Is Both a Proliferative and an Antiapoptotic Factor in Prostate Cancer. Cancer Research. 70(14). 5818–5828. 46 indexed citations
5.
Pradhan, Manohar, Vera M. Abeler, Ben Davidson, et al.. (2010). DNA Ploidy Heterogeneity in Endometrial Carcinoma. International Journal of Gynecological Pathology. 29(6). 572–578. 9 indexed citations
6.
Pradhan, Manohar, Ben Davidson, Claes G. Tropé, et al.. (2009). Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas—an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(6). 677–683. 8 indexed citations
7.
Arnoldussen, Yke Jildouw, Petra I. Lorenzo, Håkon Wæhre, et al.. (2008). The Mitogen-Activated Protein Kinase Phosphatase Vaccinia H1–Related Protein Inhibits Apoptosis in Prostate Cancer Cells and Is Overexpressed in Prostate Cancer. Cancer Research. 68(22). 9255–9264. 48 indexed citations
8.
Klokk, Tove Irene, Anette Kilander, Zhijun Xi, et al.. (2007). Kallikrein 4 Is a Proliferative Factor that Is Overexpressed in Prostate Cancer. Cancer Research. 67(11). 5221–5230. 76 indexed citations
9.
Davidson, Ben, Rivka Hadar, Ana Slipicevic, et al.. (2007). Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Human Pathology. 39(1). 87–95. 91 indexed citations
10.
Davidson, Ben, Bjørn Risberg, Neta Ilan, et al.. (2006). Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Gynecologic Oncology. 104(2). 311–319. 35 indexed citations
11.
Schaner, Marci E., Ben Davidson, Martina L. Skrede, et al.. (2005). Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients. Molecular Cancer. 4(1). 26–26. 22 indexed citations
12.
Kildal, Wanja, Bjørn Risberg, Vera M. Abeler, et al.. (2005). β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: A study in 253 patients. European Journal of Cancer. 41(8). 1127–1134. 54 indexed citations
13.
Suo, Zhenhe, et al.. (2003). Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology. 42(6). 546–554. 32 indexed citations
14.
Kildal, Wanja, Sigrid Marie Kraggerud, Vera M. Abeler, et al.. (2003). Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female. Human Pathology. 34(9). 946–949. 14 indexed citations
15.
Suo, Zhenhe, et al.. (2001). EGFR family expression in breast carcinomas. c‐erbB‐2 and c‐erbB‐4 receptors have different effects on survival. The Journal of Pathology. 196(1). 17–25. 185 indexed citations
16.
Jin, Yuesheng, Fredrik Mertens, Bertil Persson, et al.. (1998). Nonrandom Numerical Chromosome Abnormalities in Basal Cell Carcinomas. Cancer Genetics and Cytogenetics. 103(1). 35–42. 15 indexed citations
17.
Jin, Y., Bertil Persson, Hans Petter Gullestad, et al.. (1997). The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas.. PubMed. 57(3). 404–6. 19 indexed citations
18.
Lindgren, R., Bjørn Risberg, Mats Hammar, Göran Berg, & J. Pryse‐Davies. (1992). Endometrial effects of transdermal estradiol/norethisterone acetate. Maturitas. 15(1). 71–78. 28 indexed citations
19.
Högberg, Thomas, et al.. (1992). Nuclear morphometry: a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer. International Journal of Gynecological Cancer. 2(4). 198–206. 13 indexed citations
20.
Sorbe, Bengt, B. Frankendal, & Bjørn Risberg. (1989). Intracavitary irradiation of endometrial carcinoma stage I by a high dose-rate afterloading technique. Gynecologic Oncology. 33(2). 135–145. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Saegusa Breakdown of academic impact, for papers by K. Czerwenka Breakdown of academic impact, for papers by Reinhard Horvat Breakdown of academic impact, for papers by Claes G. Tropé Breakdown of academic impact, for papers by Stefania Bellone Breakdown of academic impact, for papers by Paulette Mhawech‐Fauceglia Breakdown of academic impact, for papers by Kenjiro Sawada Breakdown of academic impact, for papers by Jakob Dupont Breakdown of academic impact, for papers by Elisabeth Müller‐Holzner Breakdown of academic impact, for papers by Karin Milde‐Langosch
Rankless by CCL
2026